A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome

NCT02257697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Nephrotic Syndrome

Interventions

DRUG: Mizoribine (MZR)
DRUG: Cyclophosphamide (CTX)

Sponsor

Asahi Kasei Therapeutics Corporation